Pneumonia, a respiratory infection induces acute or chronic
inflammation, characterized by increased activity of lymphocytes and
neutrophils, thus generating oxygen-free radicals that decrease the endogenous
antioxidants defence system. Greenwayodendron suaveolens (Engl. & Diels)
Verdc. is used by the population of Cameroon to treat gonorrhoea, infertility,
malaria, stomach ache, headache, epilepsy, toothache psychosis and rheumatism.
It’s also considered as facilitating childbirth, diuretic, purgative and aphrodisiac.
There is limited documented data are available on the preventive or curative
effect of G. suaveolens species on oxidative stress and inflammatory damage.
The aim of this experimental study focused on the capacity of nontoxic aqueous,
hydroethanolic and ethanolic extracts of Greenwayodendron suaveolens (Engl.
& Diels) Verdc. subsp. suaveolens to regulate free reactive species and
protein inflammation generated by infectious disease. The phytochemical
screenings of G. suaveolens extracts were carried out according to
precipitation and colorimetric methods. The total antioxidant and flavonoid
contents were determined by the Folin-Ciocalteu and Aluminium Chloride
ethanolic methods. The efficiency of G. suaveolens extracts on free radicals
was evaluated using DPPH•, ABTS+•, and FRAP methods. The anti-inflammatory
properties of extracts were evaluated according to in vitro protein (BSA)
denaturation, Proteinase Inhibitory Action, and Red Blood Cell Membrane
stabilization assays. The G. suaveolens aqueous, hydroethanolic and ethanolic
extracts were used for the acute toxicity assessment according to the OECD
protocol. One-way ANOVA (Tukey’s and Dunnett’s tests) was used for analysis. A
difference between standard molecules and G. suaveolens extracts concentrations
was considered significant at p < 0.05. The obtained results showed the
presence of flavonoids, phenols, polyphenols, tannins, anthocyanins, alkaloids,
terpenoids, and sterols as secondary metabolites families in G. suaveolens
extracts. The highest contents of total antioxidants and flavonoids were
highlighted in the hydroethanolic extract. However, it’s the G. suaveolens
aqueous extract that showed the best free radical DPPH• and ABTS+• scavenging
activities (SC50) of 11.06 µg/mL and 15.16 µg/mL respectively. The highest
ferric-reducing activity was found in G. suaveolens ethanolic extract with
866.23 µg EGA/mg of dry weight. The hydroethanolic extract has shown a high
anti-inflammatory activity through BSA denaturation and erythrocyte membrane haemolysis
with inhibitory concentrations 50 (IC50) of 48.63 and 59.22 µg/mL respec-
tively. In contrast, proteinase inhibitory activity revealed a better potential
of IC50 (34.19 µg/mL) for the ethanolic extract. In oral acute toxicity, all
treated groups revealed neither mortality nor any significant alteration in
behaviour and locomotion. The lethal dose 50 (LD50) of G. suaveolens extracts
was >5000 mg/kg. Lower respiratory tract diseases, the main
pathophysiological mechanism of which is inflammation is mainly induced by
reactive oxygen species. These diseases are caused by microorganisms and the
immune system response of the host. In vitro study of G. suaveolens stem-barks
extracts revealed the antioxidant and anti-inflammatory activities of this
plant. These results suggest that G. suaveolens stem-barks extracts may serve
as therapeutic sources to prevent inflammation induced by oxidative stress, an
important feature of infectious diseases.
Author (s) Details
Patrick Hervé Diboue
Betote
Laboratory of Pharmacology and Drugs Discovery, Centre for Research on
Medicinal Plants and Traditional Medicine, Institute of Medical Research and
Medicinal Plants Studies, Yaoundé, Cameroon, Laboratory of Microbiology,
Department of Microbiology, Faculty of Science, University of Yaoundé I,
Yaoundé, Cameroon and Multidisciplinary Laboratory, Department of Galenical
Pharmacy and Pharmaceutical Law, Faculty of Medicine and Biomedical, Sciences,
University of Yaoundé I, Yaoundé, Cameroon.
Moustapha Gambo
Abdoulaye
Department of Physicochemical and Pharmaceutical Sciences, Faculty of
Health Sciences, Abdou Moumouni University, Niamey, Niger.
Francis Ngolsou
Multidisciplinary Laboratory, Department of Galenical Pharmacy and
Pharmaceutical Law, Faculty of Medicine and Biomedical, Sciences, University of
Yaoundé I, Yaoundé, Cameroon and Department of Pharmaceutical and Biological
Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of
Douala, Douala, Cameroon.
Esther Del Florence
Ndedi Moni
Laboratory of Microbiology, Department of Microbiology, Faculty of Science,
University of Yaoundé I, Yaoundé, Cameroon.
Gabriel A. Agbor
Laboratory of Pharmacology and Drugs Discovery, Centre for Research on
Medicinal Plants and Traditional Medicine, Institute of Medical Research and
Medicinal Plants Studies, Yaoundé, Cameroon.
Nga Nnanga
Multidisciplinary Laboratory, Department of Galenical Pharmacy and
Pharmaceutical Law, Faculty of Medicine and Biomedical, Sciences, University of
Yaoundé I, Yaoundé, Cameroon, Department of Pharmaceutical and Biological
Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of
Douala, Douala, Cameroon and Laboratory of Pharmaceutical Technology, Centre
for Research on Medicinal Plants and Traditional Medicine, Institute of Medical
Research and Medicinal Plants Studies, Yaoundé, Cameroon.
Maximilienne
Ascension Nyegue
Laboratory of Microbiology, Department of Microbiology, Faculty of Science,
University of Yaoundé I, Yaoundé, Cameroon.
Please see the book here:- https://doi.org/10.9734/bpi/prrat/v8/2278